XML 71 R48.htm IDEA: XBRL DOCUMENT v3.22.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation Expenses

Share‑based compensation was recognized in operating cost and expenses for the years ended December 31, 2018, 2020 and 2021 as follows:

 

 

 

For the Year Ended December 31,

 

 

 

2019

 

 

2020

 

 

2021

 

 

 

(RMB in thousands)

 

Processing and servicing cost

 

 

10,472

 

 

 

11,391

 

 

 

9,968

 

Sales and marketing expenses

 

 

28,611

 

 

 

32,486

 

 

 

30,508

 

Research and development expenses

 

 

42,977

 

 

 

46,116

 

 

 

39,413

 

General and administrative expenses

 

 

95,202

 

 

 

108,832

 

 

 

107,995

 

Total share‑based compensation expenses

 

 

177,262

 

 

 

198,825

 

 

 

187,884

 

Summary of Number of Shares Available for Issuance

The following table sets forth a summary of the number of shares available for issuance:

 

 

Shares Available

 

 

 

(In thousands)

 

December 31, 2018

 

 

13,833

 

Additions

 

 

3,512

 

Granted

 

 

(10,849

)

Cancelled/forfeited

 

 

1,903

 

December 31, 2019

 

 

8,399

 

Additions

 

 

3,594

 

Granted

 

 

(3,005

)

Cancelled/forfeited

 

 

2,539

 

December 31, 2020

 

 

11,527

 

Additions

 

 

3,641

 

Granted

 

 

(13,736

)

Cancelled/forfeited

 

 

5,201

 

December 31, 2021

 

 

6,633

 

Schedule of Activities for Stock Options

The following table sets forth the summary of activities for stock options granted to employees, directors and non-employee directors:

 

 

 

Options
Outstanding

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Life

 

 

Aggregate
Intrinsic
Value

 

 

 

(In thousands)

 

 

US$

 

 

(In years)

 

 

(RMB in
thousands)

 

December 31, 2018

 

 

20,142

 

 

 

1.5164

 

 

 

7.95

 

 

 

353,559

 

Granted*

 

 

5,091

 

 

 

0.5000

 

 

 

 

 

 

 

Exercised

 

 

(7,798

)

 

 

0.2548

 

 

 

 

 

 

 

Cancelled/forfeited

 

 

(1,194

)

 

 

2.3996

 

 

 

 

 

 

 

December 31, 2019

 

 

16,241

 

 

 

1.7386

 

 

 

8.22

 

 

 

589,871

 

Granted*

 

 

2,829

 

 

 

0.5000

 

 

 

 

 

 

 

Exercised

 

 

(3,140

)

 

 

0.2399

 

 

 

 

 

 

 

Cancelled/forfeited

 

 

(2,270

)

 

 

2.1589

 

 

 

 

 

 

 

December 31, 2020

 

 

13,660

 

 

 

1.7569

 

 

 

7.87

 

 

 

189,072

 

Granted*

 

 

13,489

 

 

 

0.5000

 

 

 

 

 

 

 

Exercised

 

 

(2,426

)

 

 

0.4529

 

 

 

 

 

 

 

Cancelled/forfeited

 

 

(4,594

)

 

 

3.2215

 

 

 

 

 

 

 

December 31, 2021

 

 

20,129

 

 

 

0.7227

 

 

 

8.43

 

 

 

155,018

 

Vested and expected to vest as of December 31, 2021

 

 

18,867

 

 

 

0.7355

 

 

 

8.42

 

 

 

143,684

 

Exercisable as of December 31, 2021

 

 

4,447

 

 

 

1.2408

 

 

 

6.53

 

 

 

19,540

 

 

* No stock options were granted to non-employee directors for the years presented.

The following table sets forth the summary of activities for stock options granted to non‑employees:

 

 

Options
Outstanding

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Life

 

 

Aggregate
Intrinsic
Value

 

 

 

(In thousands)

 

 

US$

 

 

(In years)

 

 

(RMB in
thousands)

 

December 31, 2018

 

 

500

 

 

 

0.0001

 

 

 

8.58

 

 

 

12,439

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(90

)

 

 

0.0001

 

 

 

 

 

 

 

Cancelled/forfeited

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2019

 

 

410

 

 

 

0.0001

 

 

 

7.58

 

 

 

19,864

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Cancelled/forfeited

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2020

 

 

410

 

 

 

0.0001

 

 

 

6.58

 

 

 

8,962

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(160

)

 

 

0.0001

 

 

 

 

 

 

 

Cancelled/forfeited

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2021

 

 

250

 

 

 

0.0001

 

 

 

5.58

 

 

 

3,076

 

Vested and expected to vest as of December 31, 2021

 

 

250

 

 

 

0.0001

 

 

 

5.58

 

 

 

3,076

 

Exercisable as of December 31, 2021

 

 

250

 

 

 

0.0001

 

 

 

5.58

 

 

 

3,076

 

Schedule of Estimated Fair Value of Stock Option Granted the estimated fair value of each stock option granted is estimated on the date of grant using the binomial option-pricing model with the following assumptions:

 

 

 

For the Year Ended December 31,

 

 

 

2019

 

 

2020

 

 

2021

 

Expected volatility

 

41.81%~42.09%

 

 

45.25%~48.26%

 

 

46.68%~47.79%

 

Risk-free interest rate (per annum)

 

1.80%~1.81%

 

 

0.67%~0.88%

 

 

1.11%~1.64%

 

Exercise multiples

 

1.5~2.5

 

 

 

2

 

 

1.5~2.5

 

Expected dividend yield

 

 

 

 

 

 

 

 

 

Expected term (in years)

 

 

10

 

 

 

10

 

 

 

10

 

Fair value of the underlying shares on the date of grants (US$)

 

5.02~6.02

 

 

3.15~4.15

 

 

1.91~6.31

 

Summary of Activities for Restricted Shares Units

The following table sets forth the summary of activities for restricted share units granted to employees, directors and non-employee directors:

 

 

Shares
Outstanding

 

 

Weighted
Average
Grant Date
Fair Value

 

 

 

(In thousands)

 

 

US$

 

December 31, 2018

 

 

1,237

 

 

 

7.47

 

Granted*

 

 

5,758

 

 

 

5.10

 

Vested

 

 

(292

)

 

 

7.49

 

Cancelled/forfeited

 

 

(709

)

 

 

5.78

 

December 31, 2019

 

 

5,994

 

 

 

5.39

 

Granted*

 

 

176

 

 

 

4.27

 

Vested

 

 

(1,527

)

 

 

5.43

 

Cancelled/forfeited

 

 

(989

)

 

 

5.57

 

December 31, 2020

 

 

3,654

 

 

 

5.27

 

Granted*

 

 

247

 

 

 

3.21

 

Vested

 

 

(1,226

)

 

 

5.35

 

Cancelled forfeited

 

 

(607

)

 

 

5.12

 

December 31, 2021

 

 

2,068

 

 

 

5.02

 

 

* No restricted share units were granted to non-employee directors for the years presented.